In-vivo effects of nociceptin and its structural analogue [Orn9] nociceptin on the antioxidant status of rat blood and liver after carrageenan-induced paw inflammation

Central European Journal of Medicine

Volumn 5, Issue 1, 2010, Pages 123-131

  Petrov, Lubomir ^a   Tzvetanova, Elina ^a   Pavlova, Almira ^a   Alexandrova, Albena ^a   Zamfirova, Rositsa ^a   Kirkova, Margarita ^a   Todorov, Simeon ^a  

^a BULGARIAN ACADEMY OF SCIENCES   (Bulgaria)

Author keywords

orn9 N OFQ(1 13) NH2; Antioxidant enzymes; Erythrocytes; Glutathione level; Lipid peroxidation; Liver; N OFQ(1 13)NH2; Paw inflammation

Indexed keywords

CARRAGEENAN; CATALASE; GLUTATHIONE; GLUTATHIONE PEROXIDASE; GLUTATHIONE REDUCTASE; HEMOGLOBIN; NOCICEPTIN; NOCICEPTIN[9 ORNITHINE]; SUPEROXIDE DISMUTASE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; ERYTHROBLAST; HEMATOCRIT; HEMOGLOBIN BLOOD LEVEL; IN VIVO STUDY; LIPID PEROXIDATION; LIVER; MALE; NONHUMAN; OXIDATIVE STRESS; PAW EDEMA; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN STRUCTURE; RAT;

EID: 77953122816     PISSN: 18951058     EISSN: 16443640     Source Type: Journal    
DOI: 10.2478/s11536-009-0117-3     Document Type: Article

References (59)

1. Calo G., Guerrini R., Rizzi A., Salvadori S., Regoli D., Pharmacology of nociceptin and its receptor: a novel therapeutic target (review), Brain J. Pharmacol., 2000, 129, 1261-1283
2. Chiou L.C., Liao Y.Y., Fan P.C., Kuo P.H., Wang C.H., Riemer C., Prinssen E.P., Nociceptin/orphanin FQ peptide receptors: pharmacology and clinical implications, Curr. Drug Targets, 2007, 8(1), 117-135
3. Wei Y., Ouyang D., Liu Y., Chang Z., Tang J., Ding J., Peripheral tissue distribution of orphanin FQ precusor mRNA in stroke-prone spontaneously hypertensive rats, Clin. Med. Sci. J., 1999, 14(2), 67-70
4. Boom A., Mollereau C., Meunier J.C., Vassart G., Parmentier M., Vanderhaeghen J.J., Schiffmann S.N., Distribution of the nociceptin and nocistatin precursor transcript in the mouse central nervous system, Neuroscience, 1999, 91(3), 991-1007
5. Doggrell S.A., Cardiovascular and renal effects of nociceptin/orphanin FQ: a new mediator to target? Curr. Opin. Investig. Drugs, 2007, 8(9), 742-749
6. Fiset M.E., Gilbert C., Poubelle P.E., Pouliot M., Human neutrophils as a source of nociceptin: a novel link between pain and inflammation, Biochemistry, 2003, 42(35), 10498-10505
7. Williams J.P., Thompson J.P., Mc Donald J., Barnes T.A., Cote T., Rowbotham D.J., Lambert D.G., Human peripheral blood mononuclear cells express nociceptin/orphanin FQ, but not mu, delta, or kappa opioid receptors, Anesth. Analg., 2007, 105(4), 998-1005
8. Williams J.P., Thompson J.P., Rowbotham D.L., Lambert D.G., Human peripheral blood mononuclear cells produce pre-pro-nociceptin/orphanin FQ mRNA, Anesth. Analg., 2008, 106(3), 865-866
9. Williams J.P., Thompson J.P., Young S.P., Gold S.J., McDonald J., Rowbotham D.J., Lambert D.J., Nociceptin and urotensin-II concentrations in critically ill patients with sepsis, Br. J. Anaesth., 2008, 100(6), 810-814
10. Hantos M.B., Szalay F., Lakatos P.L., Hegedus D., Firneisz G., Reiczigel J., et al., Elevated plasma nociceptin level in patients with Wilson disease, Brain Res. Bull., 2002, 58, 311-313
11. Ko M.H., Kim Y.H., Woo R.S., Kim K.W., Quantitive analysis of nociceptin in blood of patients with acute and chronic pain, Neuroreport, 2002, 13, 1361-1363
12. Szalay F., Hantos M.B., Horvath A., Lakatos P.L., Folhoffer A., Dunkel K., et al., Increased nociceptin/ orphanin FQ plasma levels in hepatocellular carcinoma, World J. Gastroenterol., 2004, 10(1), 42-45
13. Horvath A., Folhoffer A., Lakatos PL., Halász J., Illyés G., Schaff Z., et al., Rising plasma nociceptin level during development of HCC: A case report, World J. Gastroenterol., 2004, 10(1), 152-154
14. Mabuchi T., Matsumura S., Okuda-Ashitaka E., Kitano T., Kojima H., Nagano T., et al., Attenuation of neuropathic pain by the nociceptin/orphanin FQ antagonist JTC-801 is mediated by inhibition of nitric oxide production, Eur. J. Neurosci., 2003, 17(7), 1384-1392
15. Kulkarni M., Armstead W.M., Superoxide generation links nociceptin/orphanin FQ (NOC/oFQ) release to impaired N-methyl-D-aspartate cerebrovasodilation after brain injury, Stroke, 2000, 31, 1990-1996
16. Armstead W.M., Role of altered cyclooxygenase metabolism in impaired cerebrovasodilation to nociceptin/orphanin FQ following brain injury, Brain Res. Bull., 2000, 53, 807-812
17. Armstead W.M., NOC/oFQ PKC-dependent superoxide generation contributes to hypoxicischemic impairment of NMDAcerebrovasodilation, Am. J. Physiol. Heart Circ. Physiol., 2000, 279, H2678-H2684
18. Chen Y., Sommer C., Nociceptin and its receptor in rat dorsal root ganglion neurons in neuropathic and inflammatory pain models: implications on pain processing, J. Peripher. Nerv. Syst., 2006, 11(3), 232-240
19. Rosenberger J., Petrovics G., Buzas B., Oxidative stress induces proorphanin FQ and proenkephalin gene expression in astrocytes through p38- and ERK-MAP kinases and NF-kappaB, J. Neurochem., 2001, 79(1), 35-44
20. Naydenova E.D., Zhivkova V., Zamfirova R., Vezenkov L.T., Dobrinova Y.G., Mateeva P.I., Synthesis and biological activity of nociceptin/ orphanin FQ(1-13)NH2 analogues modified in 9 and/or 13 position, Bioorg. & Med. Chem. Lett., 2006, 16, 4071-4074
21. Helyes Z, Nemeth J, Pinter E, Szolesanyi J. (1997) Inhibition by N/OFQ of neurogenic inflammation and the release of SP and CGRP from sensory nerve terminals. Br. J. Pharmacol., 121, 613-615
22. Lowry O.H., Rosenbrough N.J., Farr A.L., Randal R.J., Protein measurement with the Folin phenol reagent, J. Biol. Chem., 1951, 193, 265-278
23. Gilbert N.S., Strump D.D., Roth E.F., A method to correct errors caused by generation of interfering compounds during erythrocyte lipid peroxidation, Anal. Biochem., 1984, 137, 282-286
24. Hunter F., Gebinski J., Hoffstein .P, Weinstein J., Scott A., Swelling and lysis of rat liver mitochondria by ferrous ions, J. Biol. Chem., 1963, 238, 828-835
25. Tietze F., Enzymatic method for quantitative determination of nanogram amounts of total and oxidized glutathione: applications to mammalian blood and other tissues, Anal. Biochem., 1969, 27, 502-522
26. GunZler W.A., Vergin H., Muller I., Flohe L., Glutathion peroxidase. VI. Die reaction der glutathion peroxidase mit Verschieden hydroperoxides Hoppe-Seyler's Z Physiol. Chem., 1972, 353, 1001-1004
27. Pinto R.E., Bartly W., The effect of age and sex on glutathione reductase and glutathione peroxidase activities and on aerobic glutathione oxidation in rat liver homogenates, Biochem. J., 1969, 112, 109-115
28. Cartier P., Leroux J.P., Marchand J.Cl., Techniques de dosage des enzymes glycocytiques tissulaires, Ann. Biol. Clin., 1967, 25, 109-136
29. Beauchamp C., Fridovich I., Superoxide dismutase: improved assays and assay applicable to acrylamide gels, Anal. Biochem., 1971, 44, 276-287
30. Aebi H., Katalase, In: Bergmeyer H.U. (Ed.), Methoden der Enzymatischen Analyze, Academie Press, Berlin, 1970
31. Zamfirova R, Tzvetanova E, Alexandrova A, Petrov L, Mateeva P, Pavlova A, Kirkova M, Todorov S., In-vivo effects of nociceptin(1-13)NH2 and its structural analogue [Orn9]nociceptin(1-13)NH2 on carrageenan-induced inflammation: rat-paw oedema and antioxidant status, Cent. Eur. J. Biol., 2009, 4(2), 170-178
32. Muntane J., Puig-Parellada P., Fernandez Y., Mitjavila S., Mitjavila M.T., Antioxidant defenses and its modulation by iron in carrageenan-induced inflammation in rats, Clin. Chim. Acta, 1993, 214(2), 185-193
33. Cuzzocrea S., Mazzon E., Dugo L., Serraino I., Ciccolo A., Centorrino Tet al., Protective effects of n-acetylcysteine on lung injury and red blood cell modification induced by carrageenan in the rat, FASEB J., 2001, 15, 1187-1200
34. Bilici D., Akpinar E., Kiziltunc A., Protective effect of melatonin in carrageenan-induced acute local inflammation, Pharmacol. Res., 2002, 46(2), 133-139
35. Chou T.C., Anti-inflammatory and analgesic effects of paeonol in carrageenan-evoked thermal hyperalgesia, Br. J. Pharmacol., 2003, 139, 1146-1152
36. Rossi A., Serraino I., Dugo P., Di Paola R., Mondello L., Genovese T., et al., Protective effects of anthocyanins from blackberry in a rat model of acute lung inflammation, Free Radic. Res., 2003, 37(8), 891-900
37. Lu T.C., Ko Y.Z., Huang H.W., Hung Y.C., Lin Y.C., Peng W.H., Analgesic and anti-inflammatory activities of aqueous extract from Glycine tomentella root in mice, J. Ethnopharmacol., 2007, 113(1), 142-148
38. Rubbo H., Radi R., Trujillo M., Telleri R., Kalyanaraman B., Barnes S., et al., Nitric oxide regulation of superoxide and peroxynitritedependent lipid peroxidation. Formation of novel nitrogen-containing oxidized lipid derivatives, J. Biol. Chem., 1994, 269, 26066-26075
39. Tracey W.R., Nakane M., Kuk J., Budzik G., Klinghofer V., Harris R., Carter G., The nitric oxide synthase inhibitor, L-NG-monomethylarginine, reduces carrageenan-induced pleurisy in the rat, J. Pharmacol. Exp. Ther., 1995, 273, 1295-1299
40. Salvemini D., Wang Z.Q., Wyatt P., Bourdon D.M., Marino M.H., Manning P.T., Currie M.G., Nitric oxide: a key mediator in the early and late phase of carrageenan-induced rat paw inflammation, Br. J. Pharmacol., 1996, 118, 829-838
41. Radi R., Beckman J.S., Bush K.M., Freeman B.A., Peroxynitrite-induced membrane lipid peroxidation: the cytotoxic potential of superoxide and nitric oxide, Arch. Biochem. Biophys., 1991, 288, 481-487
42. Peskar B.M, Trautmann M., Nowak P., Peskar, B.A., Release of 15-hydroxy-5,8,11,13-icosatetraenoic acid and cysteinyl-leukotrienes in carrageenaninduced inflammation: effect of non-steroidal antiinflammatory drugs, Agents Actions, 1991, 33(3-4), 240-246
43. Da Motta J.I., Cunha F.Q., Vargaftig B.B., Ferreira S.H., Drug modulation of antigen-induced paw oedemainguinea-pigs:effectsoflipopolysaccharide, tumour necrosis factor and leucocyte depletion, Br. J. Pharmacol., 1994, 112, 111-116
44. Wei X.Q., Charles I.G., Smith A., Ure J., Feng G.J., Huang F.P., et al., Altered immune responses in mice lacking inducible nitric oxide synthase, Nature (London), 1995, 375, 408-411
45. Salvemini D., Wang Z.Q., Bourdon D.M., Stern M.K., Currie M.G., Manning P.T., Evidence of peroxynitrite involvement in the carrageenan-induced rat paw edema, Eur. J. Pharmacol., 1996, 303, 217-220
46. Cuzzocrea S., Zingarelli B., Guard E., Hake P., Salzman A. L., Szabo' C., Protective effect of melatonin in carrageenan-induced models of local inflammation, J. Pineal Res., 1997, 23, 106-116
47. Cuzzocrea S., Caputi A.P., Zingarelli B., Peroxynitritemediated DNA strand breakage activates poly (ADP-ribose) synthetase and causes cellular energy depletion in carrageenan-induced pleurisy, Immunology, 1998, 93, 96-101 (Pubitemid 28133101)
48. Oyanagui Y., Inflammation and superoxide production by macrophages, Agents Action Suppl., 1980, 7, 174-179
49. Salvemini D., Mazzon E., Dugo L., Riley D.P., Serraino I., Caputi A.P., Cuzzocrea S., Pharmacological manipulation of the inflammatory cascade by the superoxide dismutase mimetic, M40403, Br. J. Pharmacol., 2001, 132(4), 815-827
50. Khattab M.M., TEMPOL, a membrane-permeable radical scavenger, attenuates peroxynitriteand superoxide anion-enhanced carrageenaninduced paw edema and hyperalgesia: a key role for superoxide anion, Eur. J. Pharmacol., 2006, 548(1-3), 167-173
51. Cuzzocrea S., Zingarelli B., Guard E., Hake P., Salzman A. L., Szabo' C., Protective effects of 3-aminobenzamide, an inhibitor of poly (ADPribose) synthase in carrageenan-induced models of local inflammation, Eur. J. Pharmacol., 1998, 342, 67-76
52. Cuzzocrea S., Costantino G., Mazzson E., Zingarelli B., De Sarro A., Caputi AP., Protective effects of Mn(III)tetrakis (4-benzoic acid) porphyrin (MnTBAP), a superoxide dismutase mimetic, in paw oedema induced by carrageenan in the rat, Biochem. Pharmacol., 1999, 58(1), 171-76
53. Cuzzocrea S., Mazzon E., Sautebin L., Dugo L., Serraino I., De Sarro A., Caputi A.P., Protective effects of Celecoxib on lung injury and red blood cells modification induced by carrageenan in the rat, Biochem. Pharmacol., 2002, 63(4), 785-795
54. Wu Y., Zhou C., Li X., Song L., Wu X., Lin W., et al., Evaluation of antiinflammatory activity of the total flavonoids of Laggera pterodonta on acute and chronic inflammation models, Phytother. Res., 2006, 20(7), 585-590
55. Nardi G.M., Siqueira Junior J.M., Delle Monache F., Pizzolatti M.G., Ckless K., Ribeiro-do-Valle R.M., Antioxidant and anti-inflammatory effects of products from Croton celtidifolius Bailon on carrageenaninduced pleurisy in rats, Phytomedicine, 2007, 14(2-3), 115-122
56. Haliči Z., Dengiz G.O., Odabasoglu F., Suleyman H., Cadirci E., Halici M., Amiodarone has antiinflammatory and anti-oxidative properties: an experimental study in rats with carrageenaninduced paw edema, Eur. J. Pharmacol., 2007, 566(1-3), 215-221
57. Leduc C., Gentili M.E., Estebe J.P., Le Corre P., Moulinoux J.P., Ecoffey C., The effect of local anesthetics and amitriptyline on peroxidation in vivo in an inflammatory rat model: preliminary reports, Anesth. Analg., 2002, 95(4), 992-996
58. Dhuley J.N., Raman RH., Mujumdar A.M., Naik S.R., Inhibition of lipid peroxidation by piperine during experimental inflammation in rats, Indian J. Exp. Biol., 1993, 31(5), 443-445
59. Trombella S., Vergura R., Falzarano S., Guerrini R., Calo G., Spisani S., Nociceptin/orphanin FQ stimulates human monocyte Chemotaxis via NOP receptor activation, Peptides, 2005, 26, 1497-1502